Eva Hedlund
Principal Researcher | Docent
E-mail: eva.hedlund@ki.se
Visiting address: Solnavägen 9, 17165 Solna
Postal address: C5 Cell- och molekylärbiologi, C5 CMB Hedlund, 171 77 Stockholm
Research
- The lethal motor neuron diseases (MNDs) amyotrophic lateral sclerosis (ALS)
and spinal muscular atrophy (SMA) are defined by the loss of somatic motor
neurons that innervate muscles in arms, legs, trunk and face, leading to
muscle wasting. However, not all motor neurons are equally vulnerable
certain groups of motor neurons are spared, including those in the oculomotor
nucleus, controlling eye movement and motor neurons in the Onuf's nucleus,
controlling pelvic muscles. The reasons for the differential vulnerability to
degeneration among motor neuron groups are unknown.
*Research in the Hedlund lab is aimed at elucidating mechanisms of neuronal
vulnerability and resistance with the goal of identifying new molecular
targets for the treatment of motor neuron diseases.*
Towards this goal, we utilize laser capture microdissection coupled with RNA
sequencing to dissect molecular pathways in distinct motor neuron populations
in animal models of MNDs. We also perform cross-disease analyses of
degenerative and regenerative axonal responses at neuromuscular junctions -
the specialized synapses between motor neurons and muscle.
Motor neuron cultures derived from embryonic stem cells (ESCs) and induced
pluripotent stem cells (iPSCs) harboring disease-inducing mutations are
coupled with microfluidics to model MNDs and study neuronal vulnerability and
protection in vitro. Finally, we modulate candidate gene expression in vivo
in transgenic MND mouse models to induce motor neuron protection and axonal
regeneration.
More information can be found on the lab web site. [1]
[1] http://ki.se/en/neuro/hedlund-laboratory
Articles
- Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024;78:54-63
- Article: METHODS IN MOLECULAR BIOLOGY. 2023;2594:143-164
- Article: SKELETAL MUSCLE. 2022;12(1):22
- Article: CELL METABOLISM. 2021;33(11):2215-2230.e8
- Article: NATURE MEDICINE. 2021;27(4):640-646
- Article: FRONTIERS IN MOLECULAR NEUROSCIENCE. 2021;14:699562
- Article: GLIA. 2021;69(1):124-136
- Article: NATURE COMMUNICATIONS. 2020;11(1):6341
- Article: GENOME RESEARCH. 2020;30(8):1083-1096
- Article: CELL REPORTS. 2020;31(9):107699
- Article: ACTA NEUROPATHOLOGICA. 2020;139(5):837-853
- Article: BIO-PROTOCOL. 2019;9(14):e3312
- Article: STEM CELL REPORTS. 2019;12(6):1329-1341
- Article: JOURNAL OF PHYSIOLOGY. 2019;597(12):3133-3146
- Article: HUMAN MOLECULAR GENETICS. 2019;28(10):1629-1644
- Article: NATURE. 2019;567(7747):234-238
- Article: STEM CELL REPORTS. 2018;11(6):1565-1578
- Article: NATURE IMMUNOLOGY. 2018;19(5):435-7
- Article: MOLECULAR BIOLOGY OF THE CELL. 2018;29(2):75-83
- Article: METHODS IN MOLECULAR BIOLOGY. 2018;1649:95-110
- Article: MOLECULAR METABOLISM. 2018;7:12-22
- Article: STEM CELL REPORTS. 2017;9(3):742-751
- Article: GENOME RESEARCH. 2016;26(10):1342-1354
- Article: NATURE COMMUNICATIONS. 2016;7:12139
- Article: SCIENTIFIC REPORTS. 2016;6:26448
- Article: SCIENTIFIC REPORTS. 2016;6:25960
- Article: JOURNAL OF COMPARATIVE NEUROLOGY. 2016;524(7):1424-1442
- Article: ACTA NEUROPATHOLOGICA. 2016;131(3):453-464
- Article: NEUROSCIENCE. 2015;291:216-229
- Article: STEM CELLS TRANSLATIONAL MEDICINE. 2014;3(9):1032-1042
- Article: DEVELOPMENT. 2011;138(16):3399-3408
- Article: CELL STEM CELL. 2011;8(6):663-675
- Article: BRAIN. 2010;133(Pt 8):2313-2330
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008;105(15):5856-5861
- Article: JOURNAL OF NEUROCHEMISTRY. 2006;97(5):1467-1480
- Article: EXPERIMENTAL NEUROLOGY. 2005;194(2):363-375
- Article: MOLECULAR AND CELLULAR NEUROSCIENCE. 2005;28(2):241-252
- Article: EXPERIMENTAL NEUROLOGY. 2004;190(1):122-132
- Article: JOURNAL OF NEUROSCIENCE RESEARCH. 2004;75(3):307-319
- Article: MECHANISMS OF DEVELOPMENT. 2002;114(1-2):171-175
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2001;276(26):23937-23944
- Article: TRENDS IN PHARMACOLOGICAL SCIENCES. 1998;19(3):82-85
- Article: ARCHIVES OF TOXICOLOGY. SUPPLEMENT. ARCHIV F�R TOXIKOLOGIE. SUPPLEMENT. 1998;20:455-463
- Article: MOLECULAR PHARMACOLOGY. 1996;50(2):342-350
- Show more
All other publications
- Letter: NEURON. 2023;111(23):3739-3741
- Preprint: BIORXIV. 2023
- Preprint: BIORXIV. 2022
- Review: BIOLOGY. 2022;11(8):1191
- Corrigendum: NATURE MEDICINE. 2021;27(7):1308
- Preprint: BIORXIV. 2021
- Preprint: BIORXIV. 2020
- Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2019;27:1479-1480
- Preprint: BIORXIV. 2018
- Review: MOLECULAR ASPECTS OF MEDICINE. 2018;59:36-46
- Review: ACTA NEUROPATHOLOGICA. 2017;133(6):863-885
- Conference publication: NEUROLOGY. 2017;88
- Conference publication: ACTA PHYSIOLOGICA. 2017;219:17
- Review: CELLULAR AND MOLECULAR LIFE SCIENCES. 2014;71(6):999-1015
- Review: FRONTIERS IN NEUROSCIENCE. 2014;8:109
- Review: STEM CELLS INTERNATIONAL. 2012;2012:412040-17
- Editorial comment: EXPERIMENTAL NEUROLOGY. 2011;231(1):14-18
- Review: JOURNAL OF INTERNAL MEDICINE. 2009;266(4):358-371
- Meeting abstract: MECHANISMS OF DEVELOPMENT. 2009;126:S245
- Editorial comment: CELL STEM CELL. 2008;3(6):575-576
- Review: EUROPEAN JOURNAL OF NEUROSCIENCE. 2007;26(7):1721-1737
- Review: CURRENT DRUG METABOLISM. 2001;2(3):245-263
- Thesis / dissertation: 2000
- Published conference paper: MUTATION RESEARCH - FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 1997;376(1-2):79-85
- Show more
Employments
- Principal Researcher, Department of Cell and Molecular Biology, Karolinska Institutet, 2023-
Degrees and Education
- Docent, karolinska institutet, 2011
- Doctor Of Philosophy, - No translation available -, Karolinska Institutet, 2000